marketcaparena
Search

    MRVI

    MARAVAI LIFESCIENCES HOLDINGS, INC.

    Company overview

    Market capitalization
    —
    Employees
    416
    Latest publication
    2026-09-29
    About MARAVAI LIFESCIENCES HOLDINGS, INC.

    Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The CYGNUS segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and emerging biopharmaceutical and life sciences research companies; and academic research institutions and diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue51,442,000USD65,837,000USD49,866,000USD41,630,000USD47,397,000USD46,850,000USD56,406,000USD65,200,000USD
    Cost Of Revenue30,792,000USD32,136,000USD37,624,000USD35,975,000USD39,629,000USD39,125,000USD37,444,000USD36,826,000USD
    Gross Profit20,650,000USD33,701,000USD12,242,000USD5,655,000USD7,768,000USD7,725,000USD18,962,000USD28,374,000USD
    Research Development3,702,000USD3,889,000USD3,788,000USD9,770,000USD4,882,000USD4,888,000USD4,561,000USD4,344,000USD
    Selling General Administrative32,070,000USD29,092,000USD31,583,000USD35,396,000USD38,575,000USD39,564,000USD41,243,000USD39,087,000USD
    Total Operating Expenses35,739,000USD31,227,000USD18,980,000USD-109,785,000USD74,046,000USD56,887,000USD57,092,000USD197,488,000USD
    Operating Income-15,089,000USD2,474,000USD-6,738,000USD115,440,000USD-66,278,000USD-49,162,000USD-38,130,000USD-169,114,000USD
    Total Other Income Expense Net-6,713,000USD-9,002,000USD-56,271,000USD-160,589,000USD-7,847,000USD-3,529,000USD-8,372,000USD-6,530,000USD
    Interest Income1,159,000USD1,873,000USD2,384,000USD2,797,000USD3,030,000USD3,225,000USD6,036,000USD7,071,000USD
    Interest Expense4,809,000USD5,749,000USD6,555,000USD6,844,000USD6,815,000USD6,778,000USD11,263,000USD13,634,000USD
    Income Before Tax-21,802,000USD-6,528,000USD-63,009,000USD-45,149,000USD-74,125,000USD-52,691,000USD-46,502,000USD-175,644,000USD
    Income Tax Expense-171,000USD-151,000USD6,000USD-92,000USD-4,288,000USD162,000USD-7,000USD311,000USD
    Net Income-21,631,000USD-3,733,000USD-35,681,000USD-25,556,000USD-39,591,000USD-29,945,000USD-26,145,000USD-99,038,000USD
    Minority Interest-9,215,000USD2,644,000USD27,334,000USD19,501,000USD30,246,000USD22,908,000USD20,350,000USD76,917,000USD
    Net Income Applicable To Common Shares-12,416,000USD———————
    Unclassified Operating Expenses—-1,754,000USD-16,391,000USD-154,951,000USD30,589,000USD12,435,000USD11,288,000USD154,057,000USD
    Net Interest Income—-3,876,000USD-4,171,000USD-4,047,000USD-3,785,000USD-3,553,000USD-5,227,000USD-6,563,000USD
    Tax Provision—-151,000USD6,000USD-92,000USD-4,288,000USD162,000USD-7,000USD311,000USD
    Net Income From Continuing Ops—-6,377,000USD-63,015,000USD-45,057,000USD-69,837,000USD-52,853,000USD-46,495,000USD-175,955,000USD
    Ebit—2,474,000USD-56,454,000USD-38,305,000USD-67,310,000USD-45,913,000USD-35,239,000USD-162,010,000USD
    Ebitda—15,452,000USD-41,721,000USD-22,463,000USD-51,924,000USD-31,003,000USD-20,713,000USD-147,971,000USD
    Depreciation And Amortization—12,978,000USD14,733,000USD15,842,000USD15,386,000USD14,910,000USD14,526,000USD14,039,000USD
    Reconciled Depreciation—12,978,000USD14,733,000USD15,443,000USD15,386,000USD14,910,000USD14,526,000USD14,039,000USD
    Source0001823239-26-000059DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue185,743,000USD259,185,000USD288,945,000USD883,001,000USD799,240,000USD284,098,000USD143,140,000USD123,833,000USD
    Cost Of Revenue152,353,000USD150,876,000USD148,743,000USD168,957,000USD140,561,000USD79,649,000USD66,849,000USD60,765,000USD
    Gross Profit33,390,000USD108,309,000USD140,202,000USD714,044,000USD658,679,000USD204,449,000USD76,291,000USD63,068,000USD
    Research Development23,328,000USD19,221,000USD17,280,000USD18,369,000USD15,219,000USD9,304,000USD3,627,000USD4,499,000USD
    Selling General Administrative145,118,000USD161,771,000USD150,115,000USD129,259,000USD100,064,000USD94,245,000USD48,354,000USD41,194,000USD
    Unclassified Operating Expenses-128,318,000USD162,934,000USD4,455,000USD-7,800,000USD-11,249,000USD-19,002,000USD——
    Total Operating Expenses40,128,000USD343,926,000USD171,850,000USD139,828,000USD104,034,000USD84,547,000USD52,303,000USD45,693,000USD
    Operating Income-6,738,000USD-235,617,000USD-31,648,000USD574,216,000USD554,645,000USD119,902,000USD23,988,000USD16,436,000USD
    Interest Income11,436,000USD27,403,000USD22,606,000USD2,338,000USD0USD0USD——
    Interest Expense26,992,000USD47,700,000USD45,892,000USD20,414,000USD30,260,000USD30,740,000USD29,959,000USD27,399,000USD
    Net Interest Income-15,556,000USD-20,297,000USD-18,066,000USD-18,076,000USD-30,260,000USD-30,740,000USD-29,959,000USD-27,399,000USD
    Income Before Tax-234,974,000USD-261,482,000USD617,736,000USD551,472,000USD530,765,000USD81,696,000USD-5,853,000USD-16,498,000USD
    Income Tax Expense-4,212,000USD-1,860,000USD756,111,000USD60,809,000USD61,515,000USD2,880,000USD-652,000USD417,000USD
    Tax Provision-4,212,000USD-1,860,000USD-1,610,000USD60,809,000USD61,515,000USD2,880,000USD-652,000USD417,000USD
    Net Income-130,773,000USD-144,846,000USD-119,029,000USD220,205,000USD182,037,000USD76,888,000USD-8,486,000USD-17,731,000USD
    Net Income From Continuing Ops-230,762,000USD-259,622,000USD59,036,000USD490,663,000USD469,250,000USD78,816,000USD-5,201,000USD-16,915,000USD
    Ebit-207,982,000USD-213,782,000USD663,628,000USD571,886,000USD561,025,000USD112,436,000USD24,106,000USD10,901,000USD
    Ebitda-147,111,000USD-156,917,000USD712,409,000USD609,989,000USD585,777,000USD138,273,000USD48,190,000USD33,248,000USD
    Depreciation And Amortization60,871,000USD56,865,000USD48,781,000USD38,103,000USD24,752,000USD25,837,000USD24,084,000USD22,347,000USD
    Reconciled Depreciation60,472,000USD56,865,000USD45,830,000USD38,103,000USD24,752,000USD25,837,000USD24,084,000USD22,347,000USD
    Total Other Income Expense Net-228,236,000USD-25,865,000USD649,384,000USD-22,744,000USD-23,880,000USD-38,206,000USD-29,841,000USD-32,934,000USD
    Minority Interest99,989,000USD114,776,000USD-34,472,000USD-270,458,000USD-287,213,000USD66,235,000USD3,231,000USD3,611,000USD
    Net Income Applicable To Common Shares———220,205,000USD182,037,000USD76,888,000USD-8,486,000USD-17,731,000USD
    Non Operating Income Net Other————279,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets603,746,000USD713,217,000USD770,577,000USD849,191,000USD896,966,000USD959,751,000USD1,008,244,000USD1,278,215,000USD
    Cash And Equivalents70,091,000USD———————
    Total Current Assets155,655,000USD251,736,000USD296,251,000USD325,867,000USD359,761,000USD376,282,000USD429,146,000USD679,098,000USD
    Other Current Assets13,196,000USD11,937,000USD53,863,000USD14,430,000USD15,305,000USD12,963,000USD18,145,000USD21,659,000USD
    Other Non Current Assets37,873,000USD———————
    Total Liabilities248,158,000USD———————
    Total Current Liabilities38,419,000USD42,622,000USD44,917,000USD61,574,000USD69,682,000USD63,158,000USD56,971,000USD63,241,000USD
    Other Current Liabilities30,169,000USD———————
    Other Non Current Liabilities34,168,000USD———————
    Total Stockholder Equity204,622,000USD211,564,000USD212,379,000USD245,443,000USD265,859,000USD300,614,000USD325,292,000USD345,140,000USD
    Total Equity Including Noncontrolling Interest355,588,000USD———————
    Short Long Term Debt1,125,000USD5,440,000USD5,440,000USD5,440,000USD5,440,000USD5,440,000USD5,440,000USD5,440,000USD
    Long Term Debt145,980,000USD235,571,000USD286,331,000USD287,381,000USD288,436,000USD289,499,000USD290,492,000USD516,283,000USD
    Net Receivables31,138,000USD33,415,000USD25,498,000USD22,537,000USD27,882,000USD28,493,000USD38,520,000USD28,873,000USD
    Inventory41,230,000USD40,462,000USD40,495,000USD45,326,000USD46,667,000USD49,773,000USD50,082,000USD50,409,000USD
    Property Plant Equipment Net142,414,000USD146,930,000USD1,216,000USD158,624,000USD162,727,000USD166,428,000USD217,025,000USD164,555,000USD
    Goodwill129,429,000USD———————
    Intangible Assets138,375,000USD144,887,000USD151,543,000USD185,876,000USD193,066,000USD199,581,000USD194,957,000USD201,858,000USD
    Accounts Payable7,125,000USD8,535,000USD2,910,000USD7,998,000USD11,525,000USD9,525,000USD11,957,000USD9,494,000USD
    Retained Earnings-6,031,000USD6,385,000USD10,118,000USD45,799,000USD71,355,000USD110,946,000USD140,891,000USD167,036,000USD
    Accumulated Other Comprehensive Income459,000USD466,000USD524,000USD579,000USD574,000USD324,000USD—0USD
    Total Liab—344,134,000USD397,866,000USD417,332,000USD428,983,000USD429,478,000USD431,035,000USD665,088,000USD
    Other Current Liab—28,647,000USD14,992,000USD48,136,000USD50,202,000USD44,603,000USD27,237,000USD36,631,000USD
    Common Stock—2,582,000USD2,560,000USD2,554,000USD2,553,000USD2,547,000USD2,527,000USD2,523,000USD
    Capital Stock—2,582,000USD2,560,000USD2,554,000USD2,553,000USD2,547,000USD2,527,000USD2,523,000USD
    Good Will—129,429,000USD129,429,000USD129,429,000USD129,429,000USD159,878,000USD159,878,000USD171,790,000USD
    Cash—165,922,000USD216,890,000USD243,574,000USD269,907,000USD285,053,000USD322,399,000USD578,157,000USD
    Cash And Short Term Investments—165,922,000USD216,890,000USD243,574,000USD269,907,000USD285,053,000USD322,399,000USD578,157,000USD
    Net Debt—-130,613,000USD-181,309,000USD-207,727,000USD93,682,000USD85,567,000USD54,293,000USD-17,082,000USD
    Short Term Debt—5,440,000USD5,440,000USD5,440,000USD6,316,000USD6,274,000USD13,713,000USD13,465,000USD
    Short Long Term Debt Total—35,309,000USD35,581,000USD35,847,000USD363,589,000USD370,620,000USD376,692,000USD561,075,000USD
    Property Plant Equipment Gross—146,930,000USD258,820,000USD158,624,000USD162,727,000USD166,428,000USD269,733,000USD—
    Common Stock Shares Outstanding—146,426,000shares145,074,000shares144,683,000shares144,236,000shares143,425,000shares139,730,500shares141,555,000shares
    Non Current Assets Total—461,481,000USD474,326,000USD523,324,000USD537,205,000USD583,469,000USD579,098,000USD599,117,000USD
    Non Current Liabilities Total—301,512,000USD352,949,000USD355,758,000USD359,301,000USD366,320,000USD374,064,000USD601,847,000USD
    Non Current Liabilities Other—36,072,000USD197,000USD472,000USD——423,000USD54,237,000USD
    Non Currrent Assets Other—40,235,000USD192,138,000USD49,395,000USD51,983,000USD57,582,000USD7,238,000USD60,914,000USD
    Net Working Capital—209,114,000USD251,334,000USD264,293,000USD290,079,000USD313,124,000USD372,175,000USD615,857,000USD
    Unclassified Current Liabilities—-5,440,000USD16,135,000USD-5,440,000USD-5,440,000USD-5,440,000USD-4,661,000USD-4,661,000USD
    Unclassified Non Current Liabilities—29,869,000USD66,421,000USD67,905,000USD70,865,000USD76,821,000USD83,149,000USD31,327,000USD
    Unclassified Equity—199,549,000USD196,617,000USD193,957,000USD188,824,000USD184,250,000USD179,347,000USD173,058,000USD
    Unclassified Current Assets——-40,495,000USD—————
    Current Deferred Revenue————1,639,000USD2,756,000USD3,285,000USD2,872,000USD
    Source0001823239-26-000059DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets770,577,000USD1,008,244,000USD1,487,450,000USD2,282,315,000USD1,918,276,000USD1,270,691,000USD577,796,000USD539,676,000USD
    Intangible Assets151,543,000USD194,957,000USD220,987,000USD216,663,000USD117,571,000USD177,656,000USD197,853,000USD218,127,000USD
    Other Current Assets13,368,000USD18,145,000USD17,830,000USD25,798,000USD19,698,000USD11,095,000USD3,620,000USD1,637,000USD
    Total Liab397,866,000USD431,035,000USD697,566,000USD1,377,072,000USD1,372,915,000USD1,115,945,000USD433,169,000USD391,660,000USD
    Total Stockholder Equity212,379,000USD325,292,000USD416,753,000USD545,218,000USD315,499,000USD88,511,000USD141,396,000USD144,405,000USD
    Other Current Liab14,992,000USD27,237,000USD59,525,000USD88,327,000USD61,863,000USD40,836,000USD15,713,000USD26,654,000USD
    Common Stock2,560,000USD2,527,000USD2,513,000USD2,554,000USD2,552,000USD2,576,000USD183,910,000USD182,809,000USD
    Capital Stock2,560,000USD2,527,000USD2,513,000USD2,554,000USD2,552,000USD2,576,000USD183,910,000USD182,809,000USD
    Retained Earnings10,118,000USD140,891,000USD285,737,000USD404,766,000USD184,561,000USD854,000USD-42,381,000USD-38,237,000USD
    Good Will129,429,000USD159,878,000USD326,029,000USD283,668,000USD152,766,000USD224,275,000USD224,275,000USD224,275,000USD
    Cash216,890,000USD322,399,000USD574,962,000USD632,138,000USD551,272,000USD236,184,000USD24,700,000USD21,866,000USD
    Cash And Short Term Investments216,890,000USD322,399,000USD574,962,000USD632,138,000USD551,272,000USD236,184,000USD24,700,000USD21,866,000USD
    Total Current Assets296,251,000USD429,146,000USD699,912,000USD847,902,000USD740,039,000USD331,598,000USD60,552,000USD53,802,000USD
    Total Current Liabilities44,917,000USD56,971,000USD87,468,000USD110,144,000USD93,777,000USD130,778,000USD29,562,000USD35,919,000USD
    Net Debt-181,309,000USD54,293,000USD36,005,000USD-46,876,000USD23,947,000USD354,597,000USD365,502,000USD318,023,000USD
    Short Term Debt5,440,000USD13,713,000USD12,853,000USD11,709,000USD9,722,000USD6,000,000USD2,500,000USD2,500,000USD
    Short Long Term Debt5,440,000USD5,440,000USD5,440,000USD5,440,000USD6,000,000USD6,000,000USD2,500,000USD2,500,000USD
    Short Long Term Debt Total35,581,000USD376,692,000USD610,967,000USD585,262,000USD575,219,000USD590,781,000USD390,202,000USD339,889,000USD
    Long Term Debt286,331,000USD290,492,000USD518,707,000USD521,997,000USD524,591,000USD528,614,000USD334,783,000USD335,550,000USD
    Net Receivables25,498,000USD38,520,000USD55,723,000USD146,814,000USD117,512,000USD51,018,000USD18,030,000USD15,991,000USD
    Inventory40,495,000USD50,082,000USD51,397,000USD43,152,000USD51,557,000USD33,301,000USD14,202,000USD14,308,000USD
    Accounts Payable2,910,000USD11,957,000USD10,729,000USD5,991,000USD8,154,000USD2,985,000USD7,478,000USD3,604,000USD
    Property Plant Equipment Net1,216,000USD217,025,000USD222,646,000USD116,590,000USD95,427,000USD101,305,000USD94,311,000USD42,578,000USD
    Property Plant Equipment Gross258,820,000USD269,733,000USD254,860,000USD136,092,000USD46,332,000USD101,305,000USD94,311,000USD42,578,000USD
    Accumulated Other Comprehensive Income524,000USD——0USD—-44,000USD-133,000USD-167,000USD
    Common Stock Shares Outstanding145,074,000shares137,906,000shares131,919,000shares131,695,000shares121,965,500shares96,646,515shares96,646,515shares88,965,664shares
    Non Current Assets Total474,326,000USD579,098,000USD787,538,000USD1,434,413,000USD1,178,237,000USD939,093,000USD517,244,000USD485,874,000USD
    Non Current Liabilities Total352,949,000USD374,064,000USD610,098,000USD1,266,928,000USD1,279,138,000USD985,167,000USD403,607,000USD355,741,000USD
    Non Current Liabilities Other197,000USD423,000USD2,394,000USD17,419,000USD754,547,000USD2,231,000USD1,208,000USD2,496,000USD
    Non Currrent Assets Other192,138,000USD7,238,000USD9,317,000USD40,331,000USD4,356,000USD4,158,000USD805,000USD894,000USD
    Net Working Capital251,334,000USD372,175,000USD612,444,000USD737,758,000USD646,262,000USD200,820,000USD30,990,000USD17,883,000USD
    Unclassified Current Liabilities16,135,000USD-4,661,000USD-4,439,000USD-4,411,000USD-4,602,000USD-3,104,000USD——
    Unclassified Non Current Liabilities66,421,000USD83,149,000USD88,997,000USD31,937,000USD-716,341,000USD50,559,000USD51,711,000USD—
    Unclassified Equity196,617,000USD179,347,000USD125,990,000USD135,344,000USD125,834,000USD82,549,000USD-183,910,000USD-182,809,000USD
    Current Deferred Revenue—3,285,000USD3,360,000USD3,088,000USD12,640,000USD78,061,000USD841,000USD1,087,000USD
    Unclassified Non Current Assets——8,559,000USD-28,969,000USD————
    Deferred Long Term Liab———2,200,000USD2,700,000USD3,400,000USD——
    Other Liab———693,375,000USD713,641,000USD400,363,000USD15,905,000USD18,352,000USD
    Other Assets———806,130,000USD812,473,000USD435,857,000USD805,000USD894,000USD
    Net Tangible Assets———44,887,000USD315,499,000USD-313,420,000USD-280,732,000USD-297,997,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation23,154,000USD
    Stock Based Compensation16,948,000USD
    Other Non Cash Items-3,614,000USD
    Change To Account Receivables-5,626,000USD
    Change To Inventory-735,000USD
    Change To Liabilities-1,052,000USD
    Change In Working Capital-1,337,000USD
    Operating Cash Flow12,657,000USD
    Capital Expenditures-4,807,000USD
    Other Investing Activities0USD
    Investing Cash Flow-4,807,000USD
    Net Debt Issuance-144,240,000USD
    Other Financing Activities-455,000USD
    Unclassified Financing Cash Flow-9,511,000USD
    Financing Cash Flow-154,206,000USD
    Effect Of Forex Changes On Cash47,000USD
    Change In Cash-146,309,000USD
    End Cash Flow70,581,000USD
    Source0001823239-26-000059DeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-3,733,000USD-40,107,000USD-25,556,000USD-69,837,000USD-29,945,000USD-26,145,000USD-172,027,000USD-7,585,000USD
    Depreciation12,978,000USD4,416,000USD15,842,000USD15,386,000USD14,910,000USD15,184,000USD14,039,000USD14,547,000USD
    Stock Based Compensation6,743,000USD3,926,000USD9,056,000USD6,789,000USD10,403,000USD10,545,000USD13,050,000USD13,763,000USD
    Other Non Cash Items5,245,000USD32,346,000USD-21,478,000USD36,255,000USD-10,248,000USD-1,414,000USD158,644,000USD-5,533,000USD
    Change To Account Receivables-7,914,000USD-2,961,000USD5,116,000USD501,000USD10,160,000USD-11,345,000USD5,933,000USD-2,021,000USD
    Change To Inventory33,000USD3,092,000USD1,350,000USD3,108,000USD449,000USD327,000USD-1,472,000USD751,000USD
    Change In Working Capital-5,825,000USD-19,429,000USD6,986,000USD1,142,000USD5,490,000USD-12,808,000USD1,871,000USD2,242,000USD
    Total Cash From Operating Activities8,665,000USD-22,768,000USD-15,150,000USD-10,265,000USD-9,390,000USD-14,638,000USD13,136,000USD17,434,000USD
    Capital Expenditures-4,437,000USD-2,114,000USD-2,926,000USD-2,874,000USD-5,235,000USD-5,849,000USD-9,591,000USD-9,553,000USD
    Free Cash Flow4,228,000USD-24,882,000USD-18,076,000USD-13,139,000USD-14,625,000USD-20,487,000USD3,545,000USD7,881,000USD
    Total Cashflows From Investing Activities-4,437,000USD-2,114,000USD-2,926,000USD-3,236,000USD-23,129,000USD-4,931,000USD-8,959,000USD-6,182,000USD
    Net Borrowings-51,360,000USD-790,000USD-1,560,000USD-1,547,000USD-1,543,000USD-229,540,000USD-1,520,000USD—
    Total Cash From Financing Activities-55,226,000USD-1,816,000USD-8,249,000USD-1,534,000USD-4,900,000USD-236,189,000USD809,000USD228,000USD
    Change In Cash-50,968,000USD-26,684,000USD-26,333,000USD-15,146,000USD-37,346,000USD-255,758,000USD4,986,000USD11,480,000USD
    Begin Period Cash Flow216,890,000USD243,574,000USD269,907,000USD285,053,000USD322,399,000USD578,157,000USD573,171,000USD561,691,000USD
    End Period Cash Flow165,922,000USD216,890,000USD243,574,000USD269,907,000USD285,053,000USD322,399,000USD578,157,000USD573,171,000USD
    Other Cashflows From Financing Activities-3,866,000USD-1,026,000USD-6,800,000USD13,000USD1,375,000USD-5,094,000USD2,329,000USD1,764,000USD
    Unclassified Operating Cash Flow-6,743,000USD-3,920,000USD————-2,441,000USD—
    Investments——-2,926,000USD-3,236,000USD-23,129,000USD-4,931,000USD-8,959,000USD-6,182,000USD
    Sale Purchase Of Stock——111,000USD——-602,000USD-19,000USD-28,000USD
    Other Cashflows From Investing Activities——-30,025,000USD—734,000USD918,000USD-368,000USD3,371,000USD
    Unclassified Investing Cash Flow——32,951,000USD2,874,000USD4,501,000USD4,931,000USD9,959,000USD6,182,000USD
    Unclassified Financing Cash Flow————-4,732,000USD——-1,508,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-130,773,000USD-259,622,000USD-119,029,000USD490,663,000USD469,250,000USD78,816,000USD-5,201,000USD-16,915,000USD
    Depreciation60,472,000USD56,865,000USD48,781,000USD38,103,000USD24,752,000USD25,837,000USD24,084,000USD22,347,000USD
    Stock Based Compensation30,174,000USD49,415,000USD34,588,000USD18,670,000USD10,458,000USD24,629,000USD1,679,000USD2,121,000USD
    Other Non Cash Items20,730,000USD171,104,000USD-690,902,000USD-8,695,000USD-6,163,000USD-7,524,000USD2,422,000USD7,785,000USD
    Change To Account Receivables12,816,000USD14,359,000USD84,395,000USD-22,272,000USD-70,391,000USD-33,144,000USD-1,888,000USD-4,146,000USD
    Change To Inventory7,999,000USD377,000USD649,000USD9,459,000USD-21,574,000USD-19,099,000USD106,000USD2,311,000USD
    Change In Working Capital-7,982,000USD-12,614,000USD97,844,000USD-45,082,000USD-176,631,000USD35,893,000USD2,290,000USD-15,841,000USD
    Total Cash From Operating Activities-57,573,000USD7,465,000USD126,224,000USD535,977,000USD368,570,000USD152,187,000USD24,115,000USD-186,000USD
    Capital Expenditures-13,149,000USD-29,658,000USD-65,553,000USD-17,090,000USD-14,850,000USD-25,408,000USD-17,148,000USD-3,611,000USD
    Free Cash Flow-70,722,000USD-22,193,000USD60,671,000USD518,887,000USD353,720,000USD126,779,000USD6,967,000USD-3,797,000USD
    Total Cashflows From Investing Activities-31,405,000USD-24,316,000USD-122,310,000USD-267,612,000USD105,655,000USD6,068,000USD-17,148,000USD-3,451,000USD
    Net Borrowings-5,440,000USD-234,073,000USD-5,772,000USD-5,440,000USD-6,000,000USD196,924,000USD-2,640,000USD55,428,000USD
    Total Cash From Financing Activities-16,499,000USD-235,712,000USD-61,090,000USD-187,499,000USD-159,049,000USD53,212,000USD-4,167,000USD-9,167,000USD
    Change In Cash-105,509,000USD-252,563,000USD-57,176,000USD80,866,000USD315,088,000USD211,484,000USD2,834,000USD-12,873,000USD
    Begin Period Cash Flow322,399,000USD574,962,000USD632,138,000USD551,272,000USD236,184,000USD24,700,000USD21,866,000USD34,739,000USD
    End Period Cash Flow216,890,000USD322,399,000USD574,962,000USD632,138,000USD551,272,000USD236,184,000USD24,700,000USD21,866,000USD
    Other Cashflows From Investing Activities-31,405,000USD5,342,000USD12,865,000USD-12,173,000USD548,000USD-12,173,000USD-12,173,000USD160,000USD
    Other Cashflows From Financing Activities-11,059,000USD442,999USD-55,298,000USD-184,417,000USD-154,758,000USD773,659,000USD-1,300,000USD-12,530,000USD
    Unclassified Operating Cash Flow-30,194,000USD2,317,000USD754,942,000USD42,318,000USD46,904,000USD-5,464,000USD-1,159,000USD—
    Unclassified Investing Cash Flow13,149,000USD24,316,000USD58,305,000USD29,263,000USD14,302,000USD37,581,000USD29,321,000USD3,451,000USD
    Investments—-24,316,000USD-127,927,000USD-267,612,000USD105,655,000USD6,068,000USD-17,148,000USD-3,451,000USD
    Sale Purchase Of Stock—-2,081,999USD-20,000USD0USD1,709,000USD-1,457,982,000USD-227,000USD-9,000USD
    Change To Liabilities———-8,701,000USD-7,302,000USD78,396,000USD2,550,000USD-1,670,000USD
    Issuance Of Capital Stock———0USD0USD1,758,932,000USD—0USD
    Unclassified Financing Cash Flow———2,358,000USD153,451,000USD1,149,932,000USD97,051,000USD—
    Dividends Paid————-153,451,000USD-609,321,000USD-97,051,000USD-52,056,000USD
    Cash And Cash Equivalents Changes————315,176,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific7,872,000USD0001823239-26-000024
    Q1 2026Quarterly · 2026-03-31GeographyEMEA21,947,000USD0001823239-26-000024
    Q1 2026Quarterly · 2026-03-31GeographyNorth America35,689,000USD0001823239-26-000024
    Q1 2026Quarterly · 2026-03-31GeographyOther329,000USD0001823239-26-000024
    Q4 2025Quarterly · 2025-12-31GeographyAsia Pacific14,420,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyEMEA7,679,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyNorth America27,443,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyOther324,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyAsia Pacific41,474,000USD0001823239-26-000011
    FY 2025Yearly · 2025-12-31GeographyEMEA30,921,000USD0001823239-26-000011
    FY 2025Yearly · 2025-12-31GeographyNorth America112,377,000USD0001823239-26-000011
    FY 2025Yearly · 2025-12-31GeographyOther971,000USD0001823239-26-000011
    FY 2025Yearly · 2025-12-31SegmentCygnus65,956,000USD0001823239-26-000011
    FY 2025Yearly · 2025-12-31SegmentTri Link119,787,000USD0001823239-26-000011
    Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific8,339,000USD0001823239-25-000120
    Q3 2025Quarterly · 2025-09-30GeographyEMEA7,969,000USD0001823239-25-000120
    Q3 2025Quarterly · 2025-09-30GeographyLatin And Central America296,000USD0001823239-25-000120
    Q3 2025Quarterly · 2025-09-30GeographyNorth America25,026,000USD0001823239-25-000120
    Q3 2025Quarterly · 2025-09-30SegmentBiologics Safety Testing16,277,000USD0001823239-25-000120
    Q3 2025Quarterly · 2025-09-30SegmentNucleic Acid Production25,353,000USD0001823239-25-000120
    Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific8,158,000USD0001823239-25-000107
    Q2 2025Quarterly · 2025-06-30GeographyEMEA8,395,000USD0001823239-25-000107
    Q2 2025Quarterly · 2025-06-30GeographyLatin And Central America205,000USD0001823239-25-000107
    Q2 2025Quarterly · 2025-06-30GeographyNorth America30,639,000USD0001823239-25-000107
    Q2 2025Quarterly · 2025-06-30SegmentBiologics Safety Testing16,312,000USD0001823239-25-000107
    Q2 2025Quarterly · 2025-06-30SegmentNucleic Acid Production31,085,000USD0001823239-25-000107
    Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific10,557,000USD0001823239-26-000024
    Q1 2025Quarterly · 2025-03-31GeographyEMEA6,878,000USD0001823239-26-000024
    Q1 2025Quarterly · 2025-03-31GeographyNorth America29,269,000USD0001823239-26-000024
    Q1 2025Quarterly · 2025-03-31GeographyOther146,000USD0001823239-26-000024
    Q1 2025Quarterly · 2025-03-31SegmentBiologics Safety Testing18,100,000USD0001823239-25-000063
    Q1 2025Quarterly · 2025-03-31SegmentNucleic Acid Production28,750,000USD0001823239-25-000063
    Q4 2024Quarterly · 2024-12-31GeographyAsia Pacific21,905,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyEMEA7,681,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyLatin And Central America109,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyNorth America26,863,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAsia Pacific89,378,000USD0001823239-26-000011
    FY 2024Yearly · 2024-12-31GeographyEMEA42,055,000USD0001823239-26-000011
    FY 2024Yearly · 2024-12-31GeographyNorth America127,090,000USD0001823239-26-000011
    FY 2024Yearly · 2024-12-31GeographyOther662,000USD0001823239-26-000011
    FY 2024Yearly · 2024-12-31SegmentCygnus62,840,000USD0001823239-26-000011
    FY 2024Yearly · 2024-12-31SegmentTri Link196,345,000USD0001823239-26-000011
    Q4 2024Quarterly · 2024-12-31SegmentBiologics Safety Testing14,659,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentNucleic Acid Production41,899,000USDLegacy provider
    Q3 2024Quarterly · 2024-09-30GeographyAsia Pacific22,918,000USD0001823239-25-000120
    Q3 2024Quarterly · 2024-09-30GeographyEMEA11,363,000USD0001823239-25-000120
    Q3 2024Quarterly · 2024-09-30GeographyLatin And Central America125,000USD0001823239-25-000120
    Q3 2024Quarterly · 2024-09-30GeographyNorth America34,619,000USD0001823239-25-000120
    Q3 2024Quarterly · 2024-09-30SegmentBiologics Safety Testing15,181,000USD0001823239-25-000120
    Q3 2024Quarterly · 2024-09-30SegmentNucleic Acid Production53,844,000USD0001823239-25-000120
    Q2 2024Quarterly · 2024-06-30GeographyAsia Pacific23,419,000USD0001823239-25-000107
    Q2 2024Quarterly · 2024-06-30GeographyEMEA13,646,000USD0001823239-25-000107
    Q2 2024Quarterly · 2024-06-30GeographyLatin And Central America121,000USD0001823239-25-000107
    Q2 2024Quarterly · 2024-06-30GeographyNorth America32,237,000USD0001823239-25-000107
    Q2 2024Quarterly · 2024-06-30SegmentBiologics Safety Testing14,837,000USD0001823239-25-000107
    Q2 2024Quarterly · 2024-06-30SegmentNucleic Acid Production54,586,000USD0001823239-25-000107
    Q1 2024Quarterly · 2024-03-31SegmentBiologics Safety Testing18,163,000USD0001823239-25-000063
    Q1 2024Quarterly · 2024-03-31SegmentNucleic Acid Production46,016,000USD0001823239-25-000063
    FY 2023Yearly · 2023-12-31GeographyAsia Pacific97,441,000USD0001823239-26-000011
    FY 2023Yearly · 2023-12-31GeographyEMEA49,922,000USD0001823239-26-000011
    FY 2023Yearly · 2023-12-31GeographyNorth America141,055,000USD0001823239-26-000011
    FY 2023Yearly · 2023-12-31GeographyOther530,000USD0001823239-26-000011
    FY 2023Yearly · 2023-12-31SegmentBiologics Safety Testing64,176,000USD0001823239-24-000032
    FY 2023Yearly · 2023-12-31SegmentNucleic Acid Production224,769,000USD0001823239-24-000032
    FY 2023Yearly · 2023-12-31SegmentProtein Detection0USD0001823239-24-000032
    Q4 2023Quarterly · 2023-12-31SegmentBiologics Safety Testing15,316,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31SegmentNucleic Acid Production58,825,000USDLegacy provider
    FY 2022Yearly · 2022-12-31GeographyAsia Pacific109,794,000USD0001823239-25-000034
    FY 2022Yearly · 2022-12-31GeographyEMEA432,926,000USD0001823239-25-000034
    FY 2022Yearly · 2022-12-31GeographyLatin And Central America808,000USD0001823239-25-000034
    FY 2022Yearly · 2022-12-31GeographyNorth America339,473,000USD0001823239-25-000034
    FY 2022Yearly · 2022-12-31SegmentBiologics Safety Testing69,932,000USD0001823239-24-000032
    FY 2022Yearly · 2022-12-31SegmentNucleic Acid Production813,069,000USD0001823239-24-000032
    FY 2022Yearly · 2022-12-31SegmentProtein Detection0USD0001823239-24-000032
    FY 2021Yearly · 2021-12-31GeographyAsia Pacific83,653,000USD0001823239-24-000032
    FY 2021Yearly · 2021-12-31GeographyEMEA397,674,000USD0001823239-24-000032
    FY 2021Yearly · 2021-12-31GeographyLatin And Central America842,000USD0001823239-24-000032
    FY 2021Yearly · 2021-12-31GeographyNorth America317,071,000USD0001823239-24-000032
    FY 2021Yearly · 2021-12-31SegmentBiologics Safety Testing68,417,000USD0001823239-24-000032
    FY 2021Yearly · 2021-12-31SegmentNucleic Acid Production711,864,000USD0001823239-24-000032
    FY 2021Yearly · 2021-12-31SegmentProtein Detection18,959,000USD0001823239-24-000032
    FY 2020Yearly · 2020-12-31GeographyAsia Pacific43,173,000USD0001823239-23-000014
    FY 2020Yearly · 2020-12-31GeographyEMEA90,105,000USD0001823239-23-000014
    FY 2020Yearly · 2020-12-31GeographyLatin And Central America474,000USD0001823239-23-000014
    FY 2020Yearly · 2020-12-31GeographyNorth America150,346,000USD0001823239-23-000014
    FY 2020Yearly · 2020-12-31SegmentBiologics Safety Testing54,897,000USD0001823239-23-000014
    FY 2020Yearly · 2020-12-31SegmentNucleic Acid Production206,320,000USD0001823239-23-000014
    FY 2020Yearly · 2020-12-31SegmentProtein Detection22,881,000USD0001823239-23-000014
    FY 2019Yearly · 2019-12-31GeographyAsia Pacific23,591,000USD0001823239-22-000012
    FY 2019Yearly · 2019-12-31GeographyEMEA34,882,000USD0001823239-22-000012
    FY 2019Yearly · 2019-12-31GeographyLatin And Central America642,000USD0001823239-22-000012
    FY 2019Yearly · 2019-12-31GeographyNorth America84,025,000USD0001823239-22-000012
    FY 2019Yearly · 2019-12-31SegmentBiologics Safety Testing44,416,000USD0001823239-22-000012
    FY 2019Yearly · 2019-12-31SegmentNucleic Acid Production72,602,000USD0001823239-22-000012
    FY 2019Yearly · 2019-12-31SegmentProtein Detection26,122,000USD0001823239-22-000012

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.